Mini Review
Volume 7 Issue 2 - 2020
Helicobacter pylori: A Short Literature Review
Shabina Rehman*
Department of Biochemistry, West Virginia University School of Medicine Morgantown, USA
*Corresponding Author: Shabina Rehman, Department of Biochemistry, West Virginia University School of Medicine Morgantown, USA.
Received: December 06, 2019; Published: January 10, 2020




Abstract

Several years ago, it was thought that ulcers were caused by stress, smoking or lack of exercise and so on. In 1982, it was reported that the bacteria which was responsible for most of the stomach ulcers was Helicobacter pylori (H. pylori), a bacteria, which can enter the body and live in the digestive tract. Presence of H. pylori after several years can cause ulcers in the lining of the stomach or in the upper part of small intestine, which can lead to gastric cancer. It has been documented that infection with H. pylori effects almost two-thirds of the world’s population.

However, it is now known that H. pylori doesn’t affect everyone, but evidence links H. pylori infection with gastric diseases. H. pylori infection is a global infection in developing countries. It has been documented that the occurrence of H. pylori is higher in developing countries, because the bacterium is acquired at an early age compared to developed countries. Hence, it affects over 50% in developed countries, when compared with more than 80% in developing countries. This short review will summarize important facts from the scientific literature reported over several years, and will include, but not limited to gastric cancer, infection, eradication, treatment and resistance.

Keywords: Helicobacter pylori (H. pylori); Stress; Smoking

References

  1. Mégraud., et al. “Seroepidemiology of Campylobacter pylori infection in various populations”. Journal of Clinical Microbiology 27 (1989): 1870-1873.
  2. Go MF. “Review article: natural history and epidemiology of Helicobacter pylori infection”. Alimentary Pharmacology and Therapeutics 15 (2009): 2839-2854.
  3. Ahmed KS., et al. “Prevalence study to elucidate the transmission pathways of Helicobacter pylori at oral and gastroduodenal sites of a South Indian population”. Singapore Medical Journal 47 (2006): 291-296.
  4. Mladenova I and Durazzo M. “Transmission of Helicobacter pylori”. Minerva Gastroenterologica e Dietologica 64 (2018): 251-254.
  5. Huang J-Q., et al. “Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer”. Gastroenterology 114 (1998): 1169-1179.
  6. Hansson L-E., et al. “The risk of stomach cancer in patients with gastric or duodenal ulcer disease”. The New England Journal of Medicine 4 (1996): 242-249.
  7. Fallone CA., et al. “A review of the possible bacterial determinants of clinical outcome in Helicobacter pylori infection”. Canadian Journal of Microbiology 44 (1998): 201-210.
  8. Sozzi M., et al. “Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status”. The American Journal of Gastroenterology 93 (1998): 375-379.
  9. Xiang Z., et al. “Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin”. Infection and Immunity 63 (1995): 94-98.
  10. Torre LA., et al. “Global cancer incidence and mortality rates and trends-An update”. Cancer Epidemiology Biomarkers Preview 25 (2016): 16-27.
  11. Tsukamoto T., et al. “Helicobacter pylori infection and gastric carcinogenesis in rodent models”. Seminars in Immunopathology 35 (2013): 177-190.
  12. Krakowka S., et al. “Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet”. Infection and Immunity 55 (1987): 2789-2796.
  13. Inoue M., et al. “Evaluation based on a systematic review of epidemiological evidence among Japanese populations: Tobacco smoking and total cancer risk”. Japanese Journal of Clinical Oncology 35 (2005): 404-411.
  14. Sasazuki S., et al. “Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type”. International Journal of Cancer 101 (2002): 560-566.
  15. Tian Y Wan., et al. “Androgen receptor may be responsible for gender disparity in gastric cancer”. Medical Hypotheses 80 (2013): 672-674.
  16. Tajima K and Tominaga S. “Dietary habits and gastro-intestinal cancers: A comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan”. Japanese Journal of Cancer Research 76 (1985): 705-716.
  17. Joossens JV., et al. “Dietary salt, nitrate, and stomach cancer mortality in 24 countries”. International Journal of Epidemiology 25 (1996): 494-504.
  18. Thung I., et al. “Review article: the global emergence of Helicobacter pylori antibiotic resistance”. Alimentary Pharmacology and Therapeutics 43 (2016): 514-533.
  19. Smith S., et al. “The Irish Helicobacter pylori working group consensus for the diagnosis and treatment of H pylori infection in adult patients in Ireland”. European Journal of Gastroenterology and Hepatology 29 (2017): 552-559.
  20. Liu WZ., et al. “Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection”. Helicobacter 23 (2018): 1-17.
  21. Schwartz H., et al. “Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens”. American Journal of Gastroenterology 93 (1998): 584-590.
  22. Hu C-T., et al. “Efficacy of high-dose dual therapy versus bismuth-containing quadruple therapy for first-line treatment of Helicobacter pylori infection and an interim report of multi-center, randomized control study”. Gastroenterology 152 (2017): S182-183.
  23. Sapmaz F., et al. “A non-inferiority study: modified dual therapy consisting of higher doses of rabeprazole is as successful as standard quadruple therapy in eradication of Helicobacter pylori”. American Journal of Therapeutics 24 (2017): e393-398.
  24. Koizumi W., et al. “A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori”. Journal of Gastroenterology and Hepatology 13 (1998): 301-304.
  25. Okubo M., et al. “Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication”. Journal of Gastroenterology 46 (2011): 175-182.
  26. Kiriyama Y., et al. “Gastric-and-intestinal mixed intestinal metaplasia is the irreversible point with the eradication of Helicobacter pylori”. The Journal of Pathology 6 (2016): 93-104.
  27. Kodama M., et al. “Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication”. Journal of Gastroenterology 47 (2012): 394-403.
  28. Toyokawa T., et al. “Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long-term prospective cohort study”. Journal of Gastroenterology and Hepatology 25 (2010) 544-547.
  29. Asaka M and Mabe K. “Strategies for eliminating death from gastric cancer in Japan”. Proceedings of the Japan Academy, Series. B Physical and Biological Sciences 90 (2014): 251-258.
  30. You WC., et al. “Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions”. Journal of the National Cancer Institute 98 (2006): 974-983.
  31. Leung WK., et al. “Factors predicting progression of gastric intestinal metaplasia: Results of a randomized trial on Helicobacter pylori eradication”. Gut 53 (2004): 1244-1249.
  32. Uemura N., et al. “Effect of Helicobacter pylori eradication on the subsequent development of cancer after endoscopic resection of early gastric cancer”. Cancer Epidemiology Biomarkers Preview 6 (1997): 639-642.
  33. Fukase K., et al. “Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomized controlled trial”. Lancet 372 (2008): 392-397.
  34. Bae SE., et al. “Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm”. The American Journal of Gastroenterology 109 (2014): 60-67.
  35. Chen HN., et al. “Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: Evidence from a meta-analysis”. Gastric Cancer 19 (2016): 166-175.
  36. Saka A., et al. “Endoscopic and histological features of gastric cancers after successful. Helicobacter pylori eradication therapy”. Gastric Cancer 19 (2016): 524-530.
  37. Yanaoka K., et al. “Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels”. International Journal of Cancer 125 (2009): 2697-2703.
  38. Schlemper RJ., et al. “Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: Proposal for a new classification system of gastrointestinal epithelial neoplasia”. Journal of Gastroenterology and Hepatology 15 (2000): G49-G57.
  39. Novák J., et al. “Elevated levels of anti-Helicobacter pylori antibodies in Henoch-Schönlein purpura”. Autoimmunity 36 (2003): 307-311.
  40. Hoshino C. “Adult-onset Schönlein-Henoch purpura associated with Helicobacter pylori infection”. Internal Medicine Journal 48 (2009): 847-851.
  41. Wang ZW., et al. “Helicobacter pylori infection contributes to a high risk of ischemic stroke: evidence from a meta-analysis”. Journal of Neurology 259 (2012): 2527-2537.
  42. Beydoun MA., et al. “Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey”. Psychosomatic Medicine 75 (2013): 486-496.
  43. Blecker U., et al. “Syncopes leading to the diagnosis of a Helicobacter pylori-positive chronic active hemorrhagic gastritis”. European Journal of Pediatrics 150 (1991): 560-561.
  44. Lai CY., et al. “Helicobacter pylori infection and the risk of the acute coronary syndrome: a nationwide retrospective cohort study”. European Journal of Clinical Microbiology 34 (2015): 69-74.
  45. Di Mario F., et al. “‘Rescue’ therapies for the management of Helicobacter pylori infection”. Digit Distribution 24 (2006): 113-130.
  46. Seo JH., et al. “Changing the pattern of antibiotic resistance of Helicobacter pylori in children during 20 years in Jinju, South Korea”. Pediatrics International 55 (2013): 332-336.
  47. O'Connor A., et al. “Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland”. European Journal of Gastroenterology and Hepatology 22 (2010): 1123-1127.
  48. Mégraud F and Lamouliatte H. “Review article: the treatment of refractory Helicobacter pylori infection”. Alimentary Pharmacology and Therapeutics 17 (2003): 1333-1343.
  49. Eisig JN., et al. “Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option”. Arquivos de Gastroenterologia 48 (2011): 261-264.
Citation: Shabina Rehman. “Helicobacter pylori: A Short Literature Review”. EC Gastroenterology and Digestive System 7.2 (2020): 01-09.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


January Issue Release

We Always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released January issue for the respective journals and can be viewed in the current issue pages.

Submission Deadline for March Issue

E-Cronicon delightfully welcome all the authors around the globe for an effective collaboration with an article submission for the March issue of respective journals. Submissions are accepted on/before January 31, 2020.

Certificate of Publication

E-Cronicon honours with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

E-Cronicon certify the Editors for their first review done towards assigned article of the respective journals.

Latest Articles

Latest articles will be updated immediately in the articles in press page of the respective journals.

Immediate Assistance

Prime moto of this team is to clarify all the queries without any delay or hesitation in order to avoid the inconvenience. For an immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk